Are you looking for information about osimertinib (Tagrisso)? Here's a helpful overview!
Osimertinib is a targeted therapy used to treat non-small cell lung cancer (NSCLC). It belongs to a class of drugs called EGFR inhibitors, which work by blocking a protein that tells cancer cells to grow and divide. It's used in two Show Full Answer
Are you looking for information about osimertinib (Tagrisso)? Here's a helpful overview!
Osimertinib is a targeted therapy used to treat non-small cell lung cancer (NSCLC). It belongs to a class of drugs called EGFR inhibitors, which work by blocking a protein that tells cancer cells to grow and divide. It's used in two key situations:
- When NSCLC has a specific EGFR mutation that's driving cancer growth
- When cancer cells develop a resistance mutation called T790M, which can happen after other EGFR-targeting drugs stop working
It has also been approved for use in combination with chemotherapy for EGFR-mutated NSCLC.
As with all targeted therapies, there are potential side effects to be aware of. One notable one is elevated creatine kinase levels, which can affect muscles. Always discuss any new or unusual symptoms with your care team right away.
Your doctor will determine if osimertinib is the right fit based on your specific mutation profile and treatment history.
June 25
Continue with Facebook
Continue with Email
Join
Your Privacy Choices
